N4 Pharma (N4P) News Today GBX 0.72 +0.10 (+16.00%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitors All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period N4 Pharma (LON:N4P) Stock Price Up 18.2% - What's Next?October 28, 2024 | americanbankingnews.comN4 Pharma PLC (N4P.AQ)September 20, 2024 | ca.finance.yahoo.comN4 Pharma strikes partnership deal for intracellular deliveryApril 26, 2024 | lse.co.ukN4 Pharma sees potential in Nuvec delivery method for cancer treatmentApril 19, 2024 | lse.co.ukN4 Pharma Plc Share ChatJanuary 24, 2024 | lse.co.ukN4 Pharma Acquires Major Stake in Nanogenics Through Discounted Share Placing; Shares FallSeptember 28, 2023 | marketwatch.comN4 Pharma Shares Rise After Further Nuvec Patent Granted in USJuly 25, 2023 | marketwatch.comN4 Pharma Shares Rise on Development of Nuvec TestApril 26, 2023 | marketwatch.comN4 Pharma's Pretax Loss Narrowed in 2022 on Lower R&D CostsMarch 9, 2023 | marketwatch.comMicrocap Timber Pharmaceuticals up 46% on orphan drug designation for skin disorder drugFebruary 26, 2023 | seekingalpha.comN4 Pharma Shares Rise on Positive Nuvec Oral Application ResultsJanuary 18, 2023 | marketwatch.comN4 Pharma Enhances Nuvec's Application Claims in Bid to Gain Patent ProtectionNovember 1, 2022 | marketwatch.comInstitutions profited after N4 Pharma Plc's (LON:N4P) market cap rose UK£2.9m last week butindividual investors profited the mostOctober 11, 2022 | finance.yahoo.comN4 Pharma Shares Rise on Successful Testing of Nuvec, Vaccine SystemOctober 4, 2022 | marketwatch.comN4 Pharma Narrows 1H Loss by Controlling Expenditure; Shares RiseSeptember 29, 2022 | marketwatch.comFTSE South Africa Technical AnalysisSeptember 3, 2022 | uk.investing.comN4 Pharma Plc (N4P.L)August 13, 2022 | finance.yahoo.comN4 Pharma Shares Rise on Further Nuvec ProgressJuly 15, 2022 | marketwatch.comN4 Pharma Shares Rise on Positive Results for Nuvec Delivery SystemJune 13, 2022 | marketwatch.comBeroni Group Announces Appointment of Dr. John Chiplin to Board of DirectorsMarch 31, 2022 | finance.yahoo.comN4 Pharma Says Nuvec Granted Patents in U.S., ChinaJanuary 31, 2022 | marketwatch.comN4 Pharma to Work on Nuvec With Medicines Discovery Catapult Following Encouraging ResultsJanuary 25, 2022 | marketwatch.comN4 Pharma to Focus Resources on Advancing Gene Therapy WorkDecember 13, 2021 | marketwatch.comWe Think N4 Pharma (LON:N4P) Can Afford To Drive Business GrowthAugust 30, 2021 | finance.yahoo.comN4 Pharma Says Nuvec Studies Are Progressing WellAugust 24, 2021 | marketwatch.com Get N4 Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for N4P and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW N4P Media Mentions By Week N4P Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. N4P News Sentiment▼0.000.46▲Average Medical News Sentiment N4P News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. N4P Articles This Week▼00▲N4P Articles Average Week Get N4 Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for N4P and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Haleon News Hikma Pharmaceuticals News HUTCHMED News Indivior News Alliance Pharma News Allergy Therapeutics News Animalcare Group News Beximco Pharmaceuticals News ECO Animal Health Group News Shield Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:N4P) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding N4 Pharma Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share N4 Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free N4P Stock Alerts